Yes, Sumatriptan and Naproxen Can and Should Be Taken Together
Yes, sumatriptan and naproxen can be taken together for acute migraine treatment, and this combination is explicitly recommended by the most recent clinical guidelines as superior to either medication alone. 1
Evidence-Based Recommendation
The 2025 American College of Physicians guideline provides the strongest and most recent evidence supporting this combination therapy. If patients use an adequate dose of an NSAID (like naproxen) or acetaminophen and still do not have sufficient pain relief, then add a triptan (like sumatriptan) to the NSAID. 1
Why This Combination Works Better
The combination of sumatriptan and naproxen targets multiple mechanisms involved in migraine pathogenesis, providing superior outcomes compared to monotherapy:
High-certainty evidence demonstrates that combination therapy of sumatriptan and naproxen, compared with triptan monotherapy, results in:
- 130 more patients per 1000 achieving sustained pain relief up to 48 hours 1
- 130 fewer patients per 1000 needing rescue medication at 24 hours 1
- 90 more patients per 1000 achieving pain relief at 2 hours 1
- 40 more patients per 1000 achieving sustained pain freedom at 48 hours 1
Compared to NSAID monotherapy, the combination shows even more dramatic benefits:
- 110 more patients per 1000 achieving pain freedom at 2 hours 1
- 180 more patients per 1000 achieving pain relief at 2 hours 1
- 180 more patients per 1000 achieving sustained pain relief up to 48 hours 1
- 160 fewer patients per 1000 needing rescue medication 1
Practical Implementation
Start treatment as soon as possible after migraine onset, ideally when pain is still mild. 1 This early treatment approach significantly improves efficacy compared to waiting until pain becomes moderate or severe.
Specific dosing:
- Sumatriptan: 85 mg or 50 mg (both effective) 1
- Naproxen sodium: 500 mg 1
- These can be taken as separate tablets or as a fixed-dose combination product 2
The choice between 50 mg and 85 mg sumatriptan does not significantly change outcomes 1, so the lower dose may be preferable initially to minimize adverse effects.
Safety Profile
The combination is generally well-tolerated. While adverse events are more common with the combination than with placebo (90 more events per 1000 treated people), these are typically mild to moderate and rarely lead to withdrawal 1. The adverse event profile is similar between sumatriptan/naproxen combination and sumatriptan monotherapy 3.
Common adverse effects include dizziness, dry mouth, nausea, pain/pressure sensations, and paresthesia 2, 4.
Critical Caveats
Medication overuse headache risk: Be aware that the threshold for medication overuse headache differs by drug class:
- NSAIDs (including naproxen): ≥15 days per month 1
- Triptans (including sumatriptan): ≥10 days per month 1
Contraindications to sumatriptan include:
- Coronary artery disease or vasospasm
- History of stroke or TIA
- Uncontrolled hypertension
- Recent use (within 24 hours) of another triptan or ergotamine
- Recent use (within 2 weeks) of MAO-A inhibitors 2
Do not use opioids or butalbital for acute episodic migraine treatment. 1
Treatment Algorithm
First-line for mild-moderate migraine: Start with NSAID (naproxen) or acetaminophen alone 1
If inadequate response: Add sumatriptan to naproxen (or to acetaminophen if NSAIDs contraindicated) 1
Timing: Treat early when pain is mild for best results 1
Dosing interval: If a second dose is needed, separate doses by at least 2 hours; maximum 200 mg sumatriptan in 24 hours 2
If combination fails: Consider CGRP antagonists (gepants) or other alternatives 1
The evidence strongly supports that this combination approach provides superior pain relief and functional restoration compared to either medication used alone, with an acceptable safety profile for most patients.